Categories
Jenburkt Pharmaceuticals Ltd — Board Meeting, 05-05-2026: Board Meeting
05-05-2026 · 07:15 pm
Jenburkt Pharma reported FY26 PAT of ₹34.74 Cr and Q4 PAT of ₹10.85 Cr. The Board declared a dividend of ₹220.70 (207%) per share for FY26.
No comments yet. Be the first to comment!